Diabetes refer op ghai
Your message is a bit unclear to me - "Diabetes refer op ghai" doesn't quite parse. Could you clarify what you're asking?
Asking for Preferences
What would you like to know about diabetes?
Your message is a bit unclear to me - "Diabetes refer op ghai" doesn't quite parse. Could you clarify what you're asking?
15 mark answer
Reading File
Finding Sources
Searching PubMed
"diabetes mellitus"[MeSH Terms] AND "management"[MeSH Terms]
Reading File
Reading File
Diabetes Mellitus - 15 Mark Answer
1. Definition
Diabetes Mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. It is associated with long-term damage, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels.
2. Classification
| Type | Description |
|---|---|
| Type 1 DM | Autoimmune destruction of pancreatic beta cells leading to absolute insulin deficiency; usually juvenile onset |
| Type 2 DM | Insulin resistance with relative insulin deficiency; accounts for 90-95% of all diabetics, mostly adult onset but rising in adolescents due to obesity |
| Gestational DM | Glucose intolerance first recognized during pregnancy |
| Secondary/Other specific types | Due to pancreatic disease, endocrinopathies (Cushing's, acromegaly), drug-induced (steroids, thiazides), genetic syndromes |
3. Etiology and Risk Factors
- Genetic predisposition/family history
- Obesity and sedentary lifestyle
- Age >45 years
- Autoimmune factors (Type 1)
- History of gestational diabetes or PCOS
- Hypertension, dyslipidemia
- Ethnicity (higher risk in South Asians, Hispanics, African Americans)
- Metabolic syndrome/insulin resistance
4. Pathophysiology (brief)
In Type 1 DM, autoimmune destruction of islet beta cells causes absolute insulin deficiency, leading to unopposed hepatic glucose production and lipolysis, causing hyperglycemia and ketosis. In Type 2 DM, peripheral tissues (muscle, liver, adipose) become resistant to insulin action; the pancreas compensates with increased insulin secretion until beta-cell exhaustion occurs, producing progressive hyperglycemia. Chronic hyperglycemia damages the vascular endothelium through glycation end-products and oxidative stress, driving both microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (coronary artery disease, stroke, peripheral vascular disease) complications. As noted in the Textbook of Family Medicine, diabetes is considered a coronary artery disease risk equivalent, and nearly 80% of people with diabetes die of cardiovascular disease due to diffuse atherosclerosis driven by the insulin-resistant, hyperglycemic state (Textbook of Family Medicine 9e, p. 667).
5. Clinical Features
Classical symptoms (3 P's):
- Polyuria
- Polydipsia
- Polyphagia
Other features:
- Unexplained weight loss (Type 1)
- Fatigue, weakness
- Blurred vision
- Delayed wound healing
- Recurrent infections (skin, urinary, genital candidiasis)
- Paresthesia/numbness in extremities (neuropathy)
- Nocturia
6. Diagnostic Criteria (ADA)
Any ONE of the following confirms diabetes:
- Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L)
- 2-hour plasma glucose ≥200 mg/dL during OGTT
- HbA1c ≥6.5%
- Random plasma glucose ≥200 mg/dL with classic symptoms of hyperglycemia
7. Complications
Acute:
- Diabetic ketoacidosis (DKA) - primarily Type 1
- Hyperosmolar hyperglycemic state (HHS) - primarily Type 2
- Hypoglycemia (treatment-related)
Chronic Microvascular:
- Diabetic retinopathy (leading cause of adult-onset blindness)
- Diabetic nephropathy (screened via microalbuminuria; treated with ACE inhibitors/ARBs)
- Diabetic neuropathy (peripheral and autonomic)
Chronic Macrovascular:
- Coronary artery disease/MI
- Cerebrovascular disease/stroke
- Peripheral vascular disease (diabetic foot, amputation risk)
8. Management
A. Non-pharmacological
- Medical nutrition therapy (carbohydrate counting, low glycemic index diet)
- Regular physical activity (at least 150 min/week moderate exercise)
- Weight reduction in overweight/obese patients
- Smoking cessation
- Self-monitoring of blood glucose (SMBG)
- Patient education and diabetes self-management support
B. Pharmacological
- Oral hypoglycemics: Metformin (first-line), sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists
- Insulin therapy: Mandatory in Type 1 DM; used in Type 2 DM when oral agents fail or during acute illness/pregnancy
- Adjunct therapy: Statins for dyslipidemia, antihypertensives (ACE inhibitors/ARBs preferred for renal protection)
C. Targets
- HbA1c <7% (individualized based on age, comorbidities)
- Blood pressure <130/80 mmHg
- LDL cholesterol per cardiovascular risk category
Tight control of glycemia, blood pressure, and lipids to nationally defined standards is essential for aggressive cardiovascular risk reduction in diabetic patients (Textbook of Family Medicine 9e, p. 667).
D. Nursing Management
- Regular blood glucose monitoring and documentation
- Insulin administration technique teaching (site rotation, storage)
- Foot care education (daily inspection, proper footwear, avoid barefoot walking)
- Diet counseling and meal planning
- Monitoring for signs of hypoglycemia/hyperglycemia
- Psychosocial support and motivation for lifestyle adherence
- Regular screening referrals (ophthalmology, nephrology, podiatry)
9. Prevention
- Screening high-risk individuals (obesity, family history, gestational DM history)
- Lifestyle modification programs for prediabetes
- Community health education
Recent Evidence
Current guidance continues to emphasize structured, team-based, and self-management approaches:
- A 2025 systematic review/meta-analysis found that involving specialists alongside primary care teams improves glycemic control (HbA1c) in diabetes management (PMID: 39966713).
- A 2025 systematic review of clinical practice guidelines addressed inpatient management of diabetes and hyperglycemia, reinforcing structured glucose control protocols in hospitalized patients (PMID: 40117466).
- A 2025 integrative review highlighted gaps in referral rates for Diabetes Self-Management Education and Support (DSMES) in primary care, underscoring the importance of timely referral (PMID: 39856531).
These support the standard management framework above and do not contradict it, but they emphasize increasing referral to specialist/educator support as a key improvement area in modern diabetes care.
If this is for a specific exam context (nursing, MBBS, or a particular university syllabus), let me know and I can tailor the emphasis (e.g., more nursing care plan detail, or more biochemistry/pathophysiology depth).
This is a shared conversation. Sign in to Orris to start your own chat.